Correlation Between Eupraxia Pharmaceuticals and Jupiter Neurosciences,

Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Jupiter Neurosciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Jupiter Neurosciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Jupiter Neurosciences, Common, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Jupiter Neurosciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Jupiter Neurosciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Jupiter Neurosciences,.

Diversification Opportunities for Eupraxia Pharmaceuticals and Jupiter Neurosciences,

0.06

Correlation Coefficient

Eupraxia Pharmaceuticals  Jupiter Neurosciences,

Significant diversification

The 3 months correlation between Eupraxia and Jupiter is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Jupiter Neurosciences, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jupiter Neurosciences, and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Jupiter Neurosciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jupiter Neurosciences, has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Jupiter Neurosciences, go up and down completely randomly.

Pair Corralation between Eupraxia Pharmaceuticals and Jupiter Neurosciences,

Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to under-perform the Jupiter Neurosciences,. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eupraxia Pharmaceuticals Common is 3.2 times less risky than Jupiter Neurosciences,. The pink sheet trades about -0.11 of its potential returns per unit of risk. The Jupiter Neurosciences, Common is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  549.00  in Jupiter Neurosciences, Common on September 24, 2024 and sell it today you would earn a total of  424.00  from holding Jupiter Neurosciences, Common or generate 77.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	75.0%
Values	Daily Returns

Eupraxia Pharmaceuticals Commo  vs.  Jupiter Neurosciences, Common

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Jupiter Neurosciences,

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Jupiter Neurosciences, Common are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Jupiter Neurosciences, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eupraxia Pharmaceuticals and Jupiter Neurosciences,

The main advantage of trading using opposite Eupraxia Pharmaceuticals and Jupiter Neurosciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Jupiter Neurosciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jupiter Neurosciences, will offset losses from the drop in Jupiter Neurosciences,'s long position.

The idea behind Eupraxia Pharmaceuticals Common and Jupiter Neurosciences, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.